Proteomic profiling of the human cytomegalovirus UL35 gene products reveals a role for UL35 in the DNA repair response

Journal of Virology

Volumn 86, Issue 2, 2012, Pages 806-820

  Salsman, Jayme ^a,c   Jagannathan, Madhav ^a   Paladino, Patrick ^a   Chan, Pak Kei ^b   Dellaire, Graham ^c   Raught, Brian ^b   Frappier, Lori ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; PROTEIN DCAF1; PROTEIN DDA1; PROTEIN DDB1; PROTEIN UL35; PROTEIN UL35A; PROTEIN USP7; PROTEINASE; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; VIRUS PROTEIN; VPR PROTEIN;

ARTICLE; BIOACCUMULATION; CARBOXY TERMINAL SEQUENCE; CELL CYCLE G2 PHASE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA REPAIR; GENE PRODUCT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEOMICS; VIRUS GENE;

CARRIER PROTEINS; CELL CYCLE; CELL LINE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA REPAIR; GENE EXPRESSION REGULATION, VIRAL; HOST-PATHOGEN INTERACTIONS; HUMANS; PROTEIN BINDING; PROTEOMICS; UBIQUITIN THIOLESTERASE; VIRAL PROTEINS;

HUMAN HERPESVIRUS 5; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84856860908     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05442-11     Document Type: Article

References (101)

1. Ahn JH, Hayward GS. 2000. Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression andDNAreplication in human cytomegalovirus infection. Virology 274: 39-55.
2. Andoniou CE, Degli-Esposti MA. 2006. Insights into the mechanisms of CMV-mediated interference with cellular apoptosis. Immunol. Cell Biol. 84:99-106.
3. 2 cell cycle arrest. PLoS Pathog. 6:e1001080.
4. Bergametti F, Sitterlin D, Transy C. 2002. Turnover of hepatitis B virus X protein is regulated by damaged DNA-binding complex. J. Virol. 76: 6495-6501.
5. Bernardi R, Pandolfi PP. 2007. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat. Rev. Mol. Cell Biol. 8:1006-1016.
6. 1. Virology 224:150-160.
7. Canning M, Boutell C, Parkinson J, Everett RD. 2004. A RING finger ubiquitin ligase is protected from autocatalyzed ubiquitination and degradation by binding to ubiquitin-specific protease USP7. J. Biol. Chem. 279:38160-38168.
8. Cantrell SR, Bresnahan WA. 2006. Human cytomegalovirus (HCMV) UL82 gene product (pp71) relieves hDaxx-mediated repression of HCMV replication. J. Virol. 80:6188-6191.
9. Castillo JP, Kowalik TF. 2002. Human cytomegalovirus immediate early proteins and cell growth control. Gene 290:19-34.
10. 1 cell cycle arrest through induction of cyclindependent kinase inhibitors. EMBO J. 15:2748-2759.
11. Chaurushiya MS, Weitzman MD. 2009. Viral manipulation of DNA repair and cell cycle checkpoints. DNA Repair (Amsterdam) 8:1166-1176.
12. Chelbi-Alix MK, de Thé H. 1999. Herpes virus induced proteasomedependent degradation of the nuclear bodies-associated PML and Sp100 proteins. Oncogene 18:935-941.
13. Chen HY, Tang NH, Lin N, Chen ZX, Wang XZ. 2008. Hepatitis B virus X protein induces apoptosis and cell cycle deregulation through interfering with DNA repair and checkpoint responses. Hepatol. Res. 38:174-182.
14. Choi H, et al. 2011. SAINT: probabilistic scoring of affinity purificationmass spectrometry data. Nat. Methods 8:70-73.
15. Craig R, Beavis RC. 2004. TANDEM: matching proteins with tandem mass spectra. Bioinformatics 20:1466-1467.
16. Crough T, Khanna R. 2009. Immunobiology of human cytomegalovirus: from bench to bedside. Clin. Microbiol. Rev. 22:76-98.
17. Dellaire G, Bazett-Jones DP. 2004. PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. Bioessays 26:963-977.
18. Dubaele S, Chene P. 2007. Cellular studies of MrDb (DDX18). Oncol. Res. 16:549-556.
19. Dunn W, et al. 2003. Functional profiling of a human cytomegalovirus genome. Proc. Natl. Acad. Sci. U. S. A. 100:14223-14228.
20. Everett RD. 2006. Interactions between DNA viruses, ND10 and the DNA damage response. Cell Microbiol. 8:365-374.
21. Everett RD, Meredith M, Orr A. 1999. The ability of herpes simplex virus type 1 immediate-early protein Vmw110 to bind to a ubiquitinspecific protease contributes to its roles in the activation of gene expression and stimulation of virus replication. J. Virol. 73:417-426.
22. Everett RD, et al. 1997. A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J. 16:566-577.
23. Everett RD, et al. 2006. PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0. J. Virol. 80:7995-8005.
24. Favre N, et al. 2008. Chemokine receptor CCR2 undergoes transportin1-dependent nuclear translocation. Proteomics 8:4560-4576.
25. Fortunato EA, Sanchez V, Yen JY, Spector DH. 2002. Infection of cells with human cytomegalovirus during S phase results in a blockade to immediate-early gene expression that can be overcome by inhibition of the proteasome. J. Virol. 76:5369-5379.
26. Fried H, Kutay U. 2003. Nucleocytoplasmic transport: taking an inventory. Cell Mol. Life Sci. 60:1659-1688.
27. Greis KD, Gibson W, Hart GW. 1994. Site-specific glycosylation of the human cytomegalovirus tegument basic phosphoprotein (UL32) at serine 921 and serine 952. J. Virol. 68:8339-8349.
28. Harada K, Yamada A, Yang D, Itoh K, Shichijo S. 2001. Binding of a SART3 tumor-rejection antigen to a pre-mRNA splicing factor RNPS1: a possible regulation of splicing by a complex formation. Int. J. Cancer 93:623-628.
29. Hiromura M, et al. 2003. YY1 is regulated by O-linked N-acetylglucosaminylation (O-glcNAcylation). J. Biol. Chem. 278:14046-14052.
30. Holowaty MN, Sheng Y, Nguyen T, Arrowsmith C, Frappier L. 2003. Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP. J. Biol. Chem. 278:47753-47761.
31. Holowaty MN, et al. 2003. Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7. J. Biol. Chem. 278: 29987-29994.
32. Hrecka K, et al. 2007. Lentiviral Vpr usurps Cul4-DDB1[VprBP] E3 ubiquitin ligase to modulate cell cycle. Proc. Natl. Acad. Sci. U. S. A. 104:11778-11783.
33. Huang J, Chen J. 2008. VprBP targets Merlin to the Roc1-Cul4A-DDB1 E3 ligase complex for degradation. Oncogene 27:4056-4064.
34. Hwang J, Kalejta RF. 2007. Proteasome-dependent, ubiquitinin-dependent degradation of Daxx by the viral pp71 protein in human cytomegalovirus-infected cells. Virology 367:334-338.
35. Ishov AM, Stenberg RM, Maul GG. 1997. Human cytomegalovirus immediate early interaction with host nuclear structures: definition of an immediate transcript environment. J. Cell Biol. 138:5-16.
36. Jackson S, Xiong Y. 2009. CRL4s: the CUL4-RING E3 ubiquitin ligases. Trends Biochem. Sci. 34:562-570.
37. Jault FM, et al. 1995. Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. J. Virol. 69:6697-6704.
38. Kalejta RF. 2008. Tegument proteins of human cytomegalovirus. Microbiol. Mol. Biol. Rev. 72:249-265.
39. Kalejta RF, Bechtel JT, Shenk T. 2003. Human cytomegalovirus pp71 stimulates cell cycle progression by inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors. Mol. Cell. Biol. 23:1885-1895.
40. 1 phase of the cell cycle. J. Virol. 77:3451-3459.
41. Kessner D, Chambers M, Burke R, Agus D, Mallick P. 2008. ProteoWizard: open source software for rapid proteomics tools development. Bioinformatics 24:2534-2536.
42. Khoronenkova SV, Dianova II, Parsons JL, Dianov GL. 2011. USP7/HAUSP stimulates repair of oxidative DNA lesions. Nucleic Acids Res. 39:2604-2609.
43. Kim MM, Wiederschain D, Kennedy D, Hansen E, Yuan ZM. 2007. Modulation of p53 and MDM2 activity by novel interaction with Ras-GAP binding proteins (G3BP). Oncogene 26:4209-4215.
44. Korioth F, Maul GG, Plachter B, Stamminger T, Frey J. 1996. The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. Exp. Cell Res. 229:155-158.
45. Kudoh A, et al. 2005. Epstein-Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phase-like cellular environment. J. Biol. Chem. 280:8156-8163.
46. Kudoh A, et al. 2009. Homologous recombinational repair factors are recruited and loaded onto the viral DNA genome in Epstein-Barr virus replication compartments. J. Virol. 83:6641-6651.
47. Lamarre-Vincent N, Hsieh-Wilson LC. 2003. Dynamic glycosylation of the transcription factor CREB: a potential role in gene regulation. J. Am. Chem. Soc. 125:6612-6613.
48. Le Rouzic E, et al. 2007. HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase. Cell Cycle 6:182-188.
49. Li M, et al. 2002. Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization. Nature 416:648-653.
50. Li T, Robert EI, van Breugel PC, Strubin M, Zheng N. 2010. A promiscuous alpha-helical motif anchors viral hijackers and substrate receptors to the CUL4-DDB1 ubiquitin ligase machinery. Nat. Struct. Mol. Biol. 17:105-111.
51. Li W, et al. 2010. Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus. Cell 140:477-490.
52. Liang X, et al. 2006. Deregulation of DNA damage signal transduction by herpesvirus latency-associated M2. J. Virol. 80:5862-5874.
53. Lin GY, Lamb RA. 2000. The paramyxovirus simian virus 5 V protein slows progression of the cell cycle. J. Virol. 74:9152-9166.
54. Liu G, et al. 2010. ProHits: integrated software for mass spectrometrybased interaction proteomics. Nat. Biotechnol. 28:1015-1017.
55. Liu Y, Biegalke BJ. 2002. The human cytomegalovirus UL35 gene encodes two proteins with different functions. J. Virol. 76:2460-2468.
56. Lovejoy CA, Lock K, Yenamandra A, Cortez D. 2006. DDB1 maintains genome integrity through regulation of Cdt1. Mol. Cell. Biol. 26: 7977-7990.
57. 1 to S. J. Virol. 70:8850-8857.
58. 1 phase of the cell cycle. J. Virol. 73:676-683.
59. Lukashchuk V, McFarlane S, Everett RD, Preston CM. 2008. Human cytomegalovirus protein pp71 displaces the chromatin-associated factor ATRX from nuclear domain 10 at early stages of infection. J. Virol. 82: 12543-12554.
60. Luo MH, Rosenke K, Czornak K, Fortunato EA. 2007. Human cytomegalovirus disrupts both ataxia telangiectasia mutated protein (ATM)-and ATM-Rad3-related kinase-mediated DNA damage responses during lytic infection. J. Virol. 81:1934-1950.
61. Martin-Lluesma S, et al. 2008. Hepatitis B virus X protein affects S phase progression leading to chromosome segregation defects by binding to damaged DNA binding protein 1. Hepatology 48:1467-1476.
62. McCall CM, et al. 2008. Human immunodeficiency virus type 1 Vprbinding protein VprBP, a WD40 protein associated with the DDB1-CUL4 E3 ubiquitin ligase, is essential forDNAreplication and embryonic development. Mol. Cell. Biol. 28:5621-5633.
63. Medenbach J, Schreiner S, Liu S, Luhrmann R, Bindereif A. 2004. Human U4/U6 snRNP recycling factor p110: mutational analysis reveals the function of the tetratricopeptide repeat domain in recycling. Mol. Cell. Biol. 24:7392-7401.
64. Miller-Kittrell M, Sparer TE. 2009. Feeling manipulated: cytomegalovirus immune manipulation. Virol. J. 6:4.
65. Murphy EA, Streblow DN, Nelson JA, Stinski MF. 2000. The human cytomegalovirus IE86 protein can block cell cycle progression after inducing transition into the S phase of permissive cells. J. Virol. 74: 7108-7118.
66. Nikitin PA, et al. 2010. An ATM/Chk2-mediated DNA damageresponsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells. Cell Host Microbe 8:510-522.
67. Nitzsche A, Paulus C, Nevels M. 2008. Temporal dynamics of cytomegalovirus chromatin assembly in productively infected human cells. J. Virol. 82:11167-11180.
68. Olma MH, et al. 2009. An interaction network of the mammalian COP9 signalosome identifies Dda1 as a core subunit of multiple Cul4-based E3 ligases. J. Cell Sci. 122:1035-1044.
69. Ozcan S, Andrali SS, Cantrell JE. 2010. Modulation of transcription factor function by O-GlcNAc modification. Biochim. Biophys. Acta 1799:353-364.
70. Petrik DT, Schmitt KP, Stinski MF. 2006. Inhibition of cellular DNA synthesis by the human cytomegalovirus IE86 protein is necessary for efficient virus replication. J. Virol. 80:3872-3883.
71. Precious B, Childs K, Fitzpatrick-Swallow V, Goodbourn S, Randall RE. 2005. Simian virus 5 V protein acts as an adaptor, linking DDB1 to STAT2, to facilitate the ubiquitination of STAT1. J. Virol. 79: 13434-13441.
72. Prigent M, Barlat I, Langen H, Dargemont C. 2000. IkappaBalpha and IkappaBalpha /NF-kappa B complexes are retained in the cytoplasm through interaction with a novel partner, RasGAP SH3-binding protein 2. J. Biol. Chem. 275:36441-36449.
73. Reeves MB. 2011. Chromatin-mediated regulation of cytomegalovirus gene expression. Virus Res. 157:134-143.
74. Saffert RT, Kalejta RF. 2006. Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression. J. Virol. 80:3863-3871.
75. Sakaue-Sawano A, et al. 2008. Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell 132:487-498.
76. Salsman J, Wang X, Frappier L. 2011. Nuclear body formation and PML body remodeling by the human cytomegalovirus protein UL35. Virology 414:119-129.
77. Salsman J, Zimmerman N, Chen T, Domagala M, Frappier L. 2008. Genome-wide screen of three herpesviruses for protein subcellular localization and alteration of PML nuclear bodies. PLoS Pathog. 4:e1000100.
78. Saridakis V, et al. 2005. Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBVmediated immortalization. Mol. Cell 18:25-36.
79. Sarkari F, et al. 2009. EBNA1-mediated recruitment of a histone H2B deubiquitylating complex to the Epstein-Barr virus latent origin of DNA replication. PLoS Pathog. 5:e1000624.
80. Sarkari F, Wang X, Nguyen T, Frappier L. 2011. The herpesvirus associated ubiquitin specific protease, USP7, is a negative regulator of PML proteins and PML nuclear bodies. PLoS One 6:e16598.
81. Schierling K, Buser C, Mertens T, Winkler M. 2005. Human cytomegalovirus tegument protein ppUL35 is important for viral replication and particle formation. J. Virol. 79:3084-3096.
82. Schierling K, Stamminger T, Mertens T, Winkler M. 2004. Human cytomegalovirus tegument proteins ppUL82 (pp71) and ppUL35 interact and cooperatively activate the major immediate-early enhancer. J. Virol. 78:9512-9523.
83. Sherrill JD, Miller WE. 2008. Desensitization of herpesvirus-encoded G protein-coupled receptors. Life Sci. 82:125-134.
84. Shirata N, et al. 2005. Activation of ataxia telangiectasia-mutated DNA damage checkpoint signal transduction elicited by herpes simplex virus infection. J. Biol. Chem. 280:30336-30341.
85. Sinclair J. 2010. Chromatin structure regulates human cytomegalovirus gene expression during latency, reactivation and lytic infection. Biochim. Biophys. Acta 1799:286-295.
86. Sivachandran N, Cao JY, Frappier L. 2010. Epstein-Barr virus nuclear antigen 1 hijacks the host kinase CK2 to disrupt PML nuclear bodies. J. Virol. 84:11113-11123.
87. Sivachandran N, Sarkari F, Frappier L. 2008. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies. PLoS Pathog. 4:e1000170.
88. 2 arrest. J. Virol. 81:10822-10830.
89. Tavalai N, Papior P, Rechter S, Leis M, Stamminger T. 2006. Evidence for a role of the cellular ND10 protein PML in mediating intrinsic immunity against human cytomegalovirus infections. J. Virol. 80: 8006-8018.
90. Tavalai N, Papior P, Rechter S, Stamminger T. 2008. Nuclear domain 10 components promyelocytic leukemia protein and hDaxx independently contribute to an intrinsic antiviral defense against human cytomegalovirus infection. J. Virol. 82:126-137.
91. Tavalai N, Stamminger T. 2011. Intrinsic cellular defense mechanisms targeting human cytomegalovirus. Virus Res. 157:128-133.
92. Trilling M, et al. 2011. Identification of DNA-damage DNA-binding protein 1 as a conditional essential factor for cytomegalovirus replication in interferon-gamma-stimulated cells. PLoS Pathog. 7:e1002069.
93. Varnum SM, et al. 2004. Identification of proteins in human cytomegalovirus (HCMV) particles: the HCMV proteome. J. Virol. 78: 10960-10966.
94. Weitzman MD, Lilley CE, Chaurushiya MS. 2011. Changing the ubiquitin landscape during viral manipulation of the DNA damage response. FEBS Lett. 585:2897-2906.
95. 2 cell cycle arrest by engaging a DDB1 and Cullin4A-containing ubiquitin ligase complex using VprBP/DCAF1 as an adaptor. J. Biol. Chem. 282:27046-27057.
96. Wiebusch L, Hagemeier C. 2001. The human cytomegalovirus immediate early 2 protein dissociates cellular DNA synthesis from cyclindependent kinase activation. EMBO J. 20:1086-1098.
97. Wilkinson DE, Weller SK. 2004. Recruitment of cellular recombination and repair proteins to sites of herpes simplex virus type 1 DNA replication is dependent on the composition of viral proteins within prereplicative sites and correlates with the induction of the DNA damage response. J. Virol. 78:4783-4796.
98. Woodhall DL, Groves IJ, Reeves MB, Wilkinson G, Sinclair JH. 2006. Human Daxx-mediated repression of human cytomegalovirus gene expression correlates with a repressive chromatin structure around the major immediate early promoter. J. Biol. Chem. 281:37652-37660.
99. YangWH, et al. 2006. Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat. Cell Biol. 8:1074-1083.
100. Yang WH, et al. 2008. NFkappaB activation is associated with its O-GlcNAcylation state under hyperglycemic conditions. Proc. Natl. Acad. Sci. U. S. A. 105:17345-17350.
101. Zeghouf M, et al. 2004. Sequential Peptide Affinity (SPA) system for the identification of mammalian and bacterial protein complexes. J. Proteome Res. 3:463-468.